THE EFFECT OF CLOFAZIMINE ON THE PHARMACOKINETICS OF RIFAMPICIN AND DAPSONE IN LEPROSY

被引：11
作者：
VENKATESAN, K
MATHUR, A
GIRDHAR, BK
BHARADWAJ, VP
机构：
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1986年 / 18卷 / 06期
关键词：
D O I：
10.1093/jac/18.6.715
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：715 / 718
页数：4
相关论文
共 14 条
[1]  
Balakrishnan, 1981, Lepr India, V53, P17
[2]  
CARTEL JL, 1983, INT J LEPROSY, V51, P461
[3]   ASSAY OF RIFAMPICIN IN SERUM [J].
DICKINSON, JM ;
ABER, VR ;
ALLEN, BW ;
ELLARD, GA ;
MITCHISON, DA .
JOURNAL OF CLINICAL PATHOLOGY, 1974, 27 (06) :457-462
[4]   URINE TESTS TO MONITOR SELF-ADMINISTRATION OF DAPSONE BY LEPROSY PATIENTS [J].
ELLARD, GA ;
GAMMON, PT ;
HELMY, HS ;
REES, RJW .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1974, 23 (03) :464-470
[5]  
FENG PCC, 1981, DRUG METAB DISPOS, V9, P521
[6]  
GRABOSZ JAJ, 1975, INT J LEPROSY, V43, P61
[7]  
JI BH, 1984, LEPROSY REV, V55, P283
[8]  
MATHUR A, 1986, LEPROSY REV, V57, P33
[9]  
Nakagawa H, 1973, Kekkaku, V48, P167
[10]  
PATTYN SR, 1984, INT J LEPROSY, V52, P1
12